Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CardioThrive is a private medical device company developing ultraportable automated external defibrillator technology for sudden cardiac arrest. Its lead product concept, the PocketDefib, is designed to enable rapid defibrillation by untrained bystanders outside traditional public-access AED settings. The company positions its technology as a personal or wearable defibrillation solution for people at elevated risk of sudden cardiac arrest, as well as for first responders and medical staff. Based on publicly available information, the product has not yet received FDA clearance, indicating the company remains at a pre-commercial development stage. CardioThrive appears to be focused on improving survival from out-of-hospital cardiac arrest through miniaturized, easy-to-use defibrillator devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CardioThrive.